Reuters logo
a month ago
BRIEF-IPCA Labs says USFDA states drugs from SEZ Indore, Piparia unit will be refused admission into U.S.
June 15, 2017 / 1:36 PM / a month ago

BRIEF-IPCA Labs says USFDA states drugs from SEZ Indore, Piparia unit will be refused admission into U.S.

1 Min Read

June 15 (Reuters) - Ipca Laboratories Ltd:

* US FDA update on company's formulations manufacturing units situated at SEZ Indore (Pithampur) and Piparia (Silvassa)

* Received communication from USFDA stating drugs manufactured at facilities in Indore and Piparia will be refused admission into U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below